Journals / MN Oftalmoloji / 2017 / Cilt: 24 - Sayı: 2

Choroidal Thickness and Integrity of Inner Segment-Outer Segment in Central Serous Chorioretinopathy and the Effect of Photodynamic Therapy

Santral Seröz Koryoretinopatide Koroid Kalınlığı ve İç Segment - Dış Segment Bütünlüğü ile Fotodinamik Tedavinin Etkisi

Pages
90–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results suggest that acute central serous chorioretinopathy may occur as a result of systemic factors, whereas chronicity may be a local event.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the choroidal thickness in patients with acute and chronic central serous chorioretinopathy using enhanced depth imaging-optical coherence tomography and the correlation between the integrity of the inner segment-outer segment junction and final visual acuity.
📊
Key Findings & Data:Material abd Method: In this clinical practise, subfoveal and mean choroidal thicknesses of central serous chorioretinopathy patients with 27 affected eyes, 27 non-affected fellow eyes and 31 healthy controls were analyzed using enhanced depth imaging-optical coherence tomography prospectively from October 2014 to October 2015.
💡
Conclusion & Impact:These results suggest that acute central serous chorioretinopathy may occur as a result of systemic factors, whereas chronicity may be a local event.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the choroidal thickness in patients with acute and chronic central serous chorioretinopathy using enhanced depth imaging-optical coherence tomography and the correlation between the integrity of the inner segment-outer segment junction and final visual acuity. Material abd Method: In this clinical practise, subfoveal and mean choroidal thicknesses of central serous chorioretinopathy patients with 27 affected eyes, 27 non-affected fellow eyes and 31 healthy controls were analyzed using enhanced depth imaging-optical coherence tomography prospectively from October 2014 to October 2015. Acute central serous chorioretinopathy patients were followed for at least six months with no treatment. Chronic central serous chorioretinopathy patients were treated with photodynamic therapy and followed for at least three months. During follow-up, the alteration of the choroidal thicknesses and on the final visit, the regularity of the inner segment-outer segment were analyzed. Results: The choroidal thicknesses were significantly greater in the affected eyes and the fellow eyes of acute central serous chorioretinopathy patients than in the healthy controls; however, these measurements were significantly greater in only the affected eyes of chronic central serous chorioretinopathy patients (p<0.05). In chronic central serous chorioretinopathy patients, the choroidal thicknesses were significantly decreased after photodynamic therapy, and a positive correlation was detected between the irregularity of the inner segment-outer segment junction and final visual acuity in chronic central serous chorioretinopathy patients (p<0.05). Conclusion: While acute central serous chorioretinopathy patients show choroidal thickening in affected and non-affected eyes, chronic central serous chorioretinopathy patients show it only in affected eyes. These results suggest that acute central serous chorioretinopathy may occur as a result of systemic factors, whereas chronicity may be a local event.

Özet

Amaç: Akut ve kronik santral seröz koryoretinopati hastalarında artırılmış derinlik incelemeli optik koherans tomografi kullanılarak koroid kalınlığını ve son görme seviyesi ile iç segment dış segment bağlantısının bütünlüğü arasındaki ilişkiyi değerlendirmek.Gereç ve Yöntem: Bu klinik çalışmada, Ekim 2014-Ekim 2015 tarihleri arasında 27 santral seröz koryoretinopati hastasının hastalıktan etkilenen 27 gözü, hastalıktan etkilenmeyen 27 gözü ve 31 sağlıklı kontrolün subfoveal ve ortalama koroid kalınlıkları artırılmış derinlik incelemeli optik koherans tomografi kullanılarak prospektif olarak analiz edildi. Akut santral seröz koryoretinopati hastaları en az 6 ay tedavisiz takip edildi. Kronik santral seröz koryoretinopati hastalarına fotodinamik tedavi uygulandı ve en az 3 ay takip edildi. Takipler sırasında koroidkalınlığındaki değişiklikler ve son kontroldeki iç segment dış segment bütünlüğü analiz edildi.Bulgular: Akut santral seröz koryoretinopati hastalarının hastalıktan etkilenen gözlerinde ve hastalıktan etkilenmeyen diğer gözlerinde koroid kalınlıkları sağlıklı kontrollere göre anlamlı olarak fazlaydı; bununla birlikte bu ölçümler kronik santral seröz koryoretinopati hastalarının yalnızca hastalıktan etkilenen gözlerinde anlamlı olarak fazlaydı (p<0,05). Kronik santral seröz koryoretinopati hastalarında, fotodinamiktedavi sonrasında koroid kalınlıkları anlamlı azalma gösterdi ve son görme seviyesi ile iç segment dış segment düzensizliği arasında pozitif ilişki saptandı (p<0,05).Sonuç: Akut santral seröz koryoretinopati hastaları hastalıktan etkilenen ve hastalıktan etkilenmeyen gözlerde koroidal kalınlaşma gösterirken, kronik santral seröz koryoretinopati hastaları bunu yalnızca hastalıktan etkilenen gözlerde gösterdi. Bu sonuçlar akut santral seröz koryoretinopatinin sistemik faktörlerin bir sonucu olarak, oysa kronik santral seröz koryoretinopatinin lokal bir olay sonucu oluşabildiğini ilerisürmektedir.

🔖

Cite This Article

ÇETİNKAYA, T., SÜLLÜ, Y. (2017). Choroidal Thickness and Integrity of Inner Segment-Outer Segment in Central Serous Chorioretinopathy and the Effect of Photodynamic Therapy. MN Oftalmoloji, Cilt: 24 - Sayı: 2, 90–94. https://ajindex.com/articles/297031

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nicholson B, Noble J, Forooghian F, Meyerle C. Central Serous Chorioretinopathy: Update on pathophysiology and treatment. Surv Ophthalmol 2013;58(2):103-26
  2. Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S. Photodynamic Therapy for Central Serous Chorioretinopathy. Eye (Lond) 2014;28(8):944-57
  3. Yaylacıoğlu Tuncay F, Gürelik G. Santral Seröz Koryoretinopati Ret-Vit 2010;18:2
  4. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: II Idiopathic central serous choroidopathy. Am J Ophthalmol 1967;63:587-615
  5. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121(1):26-34
  6. Spaide RF, Hall L, Haas A et al. Indocyanine gren videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203-213
  7. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986; 224(4):321-324
  8. Bouzas EA, KAradimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47(5): 431-48
  9. Levy J, Marcus M, Belfair N, Klemperer I, Lifshitz T. Central serous chorioretinopathy in patients receiving systemic corticosteroid Therapy. Can J Ophthalmol 2005; 40(2):217-21
  10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials: TAP report. Treatment of agerelated macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999;117(10):1329-1345
  11. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999; 19(6): 508-512
  12. Dang Y, Sun X, Xu Y et al. Subfoveal choroidal thickness after photodynamic Therapy in patients with acute idiopathic central serous chorioretinopathy. Ther Clin Risk Manag 2014; 10: 37-43
  13. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011;31(8):1603-8
  14. Maruko I, Iida T, Sugano Y, Furuta M, Sekiryu T. One-year choroidal thickness results after photodynamic Therapy for central serous chorioretinopathy. Retina 2011; 31(9):1921-7
  15. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29(10):1469-73.